Flu season visitor restriction – age 16 or older (Restricción de visitantes durante la Temporada de Influenza (Flu) – Mayores de 16 años.)

Flu Season Visitor Restriction

Visitors temporarily restricted to age 16 or older

As a safety first organization, ChristianaCare is implementing a temporary visitation age restriction starting Tuesday, Jan. 21. This temporary restriction protects patients, their loved ones and health care workers during this time of extremely high number of influenza cases and other respiratory illnesses circulating in our community.

The new restrictions limit visitors to patients in Christiana and Wilmington hospitals to persons age 16 or older. Children and teens younger than 16 years are most likely to get the flu and remain contagious longer than adults. This restriction does not apply to outpatient and ambulatory services.

Thank you for your understanding and cooperation.

For more information about the Flu visit our Health Library.

Restricción de visitantes durante la Temporada de Influenza (Flu)

Temporalmente solo se permiten los visitantes mayores de 16 años.

Como una organización que promueve la seguridad ante todo, ChristianaCare está implementando una restricción temporal en la edad de visitantes a partir del viernes 21 de enero. Esta restricción temporal protege a los pacientes, a sus seres queridos y al personal de cuidados de salud durante esta época con un número extremadamente alto de casos de influenza y de otras enfermedades respiratorias que circulan en nuestra comunidad.

Las nuevas restricciones, en los hospitales Christiana y Wilmington, sólo permiten visitas a pacientes de personas mayores de 16 años. Los niños y adolescentes menores de 16 años son más propensos a contraer el flu y son contagiosos por más tiempo que los adultos. Esta restricción no aplica a las áreas de servicios ambulatorios.

Gracias por su comprensión y cooperación.

Para más información sobre la gripe, visite nuestra Biblioteca de Salud.

Cancer Research at the
Helen F. Graham Cancer Center
& Research Institute

Oncology Patient Advocates for Clinical Trials (OPACT)

Oncology Patient Advocates for Clinical Trials (OPACT) is a group of cancer survivors who have participated in clinical trials and seek to help other patients who may be considering clinical trials. We build bridges between patients, physicians, nurses, social workers and others who provide care to cancer patients considering participation in a Helen F. Graham Cancer Center & Research Institute clinical trial.

Mission & Vision

Our goal is to create awareness of the opportunities patients have in the clinical trial program. We will serve as a resource for both new patients considering clinical trials, and clinical trial practitioners to improve the the overall experience for the patient. We will communicate the trial results to patients once available and also celebrate our patients’ accomplishments through an annual event.

What is a Clinical Trial?

A clinical trial is a research study designed to answer a specific scientific question. Research clinical trials are conducted with cancer patients to determine if a new treatment or therapy is effective. Treatments can include surgery, radiation therapy and chemotherapy, either alone or in combination.

Some clinical trials are designed to study ways to prevent cancer. They are called prevention trials. Other studies examine the psychological impact of cancer, ways to improve patient quality of life, and ways to control symptoms or side effects. A clinical trial is often referred to as a protocol.

The cancer clinical trials available through the Helen F. Graham Center & Research Institute are sponsored by the National Cancer Institute (NCI) and other national research partners. The ChristianaCare cancer research program is a NCI Community Oncology Research Program (NCORP). As a NCORP member, the Helen F. Graham Cancer Center & Research Institute provides patients with the newest cancer therapies, including more than 100 clinical trials sponsored by the federal government and drug companies for the prevention and treatment of cancer at different stages.

How We Can Help

We understand what you’re going through because we’ve been there. We know how overwhelming these decisions about treating your cancer can feel. The good news is that you have options. Clinical trials offer you access to new treatments that might otherwise be unavailable.

You also have us. We are your advocates. We can help ease the burden of making these decisions by sharing our knowledge and experience with clinical studies. We know that from a patient’s perspective the more information you have, the easier it will be for you and your family to make the decision that’s right for you.

To talk with one of us, call the cancer research office at 302-623-4450.

Cancer Research Program
Helen F. Graham Cancer Center & Research Institute
4701 Ogletown-Stanton Road, Newark, DE 19713 directions
For more information, call 302-623-4450 or e-mail us.